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ABSTRACT
Objective: Nowadays, non-compliant (NC) balloon catheters 
are used to predilate heavily calcified lesions before stenting 
to postdilate the implanted stent to optimize its parameters, to 
finalize bifurcation treatment in final kissing balloon technique 
as well as to treat restenosis, especially in implanted earlier 
stents. The aim of this paper was to verify clinical effectiveness 
and safety profile of the new non-complaint balloon catheter 
(Balton, Poland).
Methods: It was the first-in-man analysis of the use of Balton 
NC balloon angioplasty catheter in patients undergoing percuta-
neous coronary interventions. There were included consecutive 
patients with age ≥ 18 years old, with coronary artery disease 
undergoing percutaneous coronary interventions in lesion 
requiring predilatation or postdilatation and who signed the 
informed consent. The local IRB approved the study protocol 
(No 135/2017). The primary endpoint was to compare balloon 
diameters obtained in QCA to diameters declared by the pro-
ducer reached at certain pressures. 
Results: A total of 21 patients were enrolled. In most cases 
patients presented with the multivessel disease (61.9%) and 
lesions of the moderate complexity (type B1 — 71.4%, type 
B2 — 4.8%). Lesions were located most frequently in the left 
circumflex artery (47.6%, n = 10). The device success rate 
was 100%. All procedures were performed via the 6F guiding 
catheter (100%) and in 95.2% (n = 20/21) the radial access 
was preferred. There were no significant differences between 
QCA and expected balloon diameters when applied the nominal 
pressure both in predilatation (2.32±0.31 mm vs. 2.38 ± 0.43 
mm, D 2.5%) as well as in postdilatation (2.90±0.38 mm vs. 
2.96 ± 0.47 mm, D 2.0%). There were only two dissection 
cases (1 type A and 1 type B).
Conclusions: The presented data confirm the effectiveness 
and safety profile of Balton NC balloon catheters. There the 
device success rate was 100%, and there were no severe 
complications. In QCA analysis Balton NC balloon catheters 
reached assumed diameters and lengths at given pressures.
Key words: balloon angioplasty, non-compliant balloon, quan-
titative coronary angiography
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STRESZCZENIE
Cel: Obecnie niepodatne cewniki (NC, non-compliant) ba-
lonowe stosuje się do przygotowania silnie uwapnionych 
zmian przed stentowaniem, do doprężenia implantowanego 
stentu w celu zoptymalizowania jego parametrów, do sfina-
lizowania zabiegu poszerzenia bifurkacji w technice kissing, 
a także w leczeniu nawrotu zwężenia, szczególnie w przypadku 
wszczepionych wcześniej stentów. Celem niniejszej pracy była 
weryfikacja skuteczności klinicznej i profilu bezpieczeństwa 
nowego niepodatnego cewnika balonowego (Balton, Polska). 
Metody: Jest to pierwsza analiza zastosowania cewnika do 
angioplastyki balonowej Balton NC u chorych poddawanych 
przezskórnej interwencji wieńcowej. Do badania włączono 
kolejnych pacjentów w wieku co najmniej 18 lat z chorobą 
niedokrwienną serca poddawanych przezskórnej interwencji 
wieńcowej w zmianach wymagających pre- lub postdilatacji 
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ai którzy podpisali świadomą zgodę. Lokalna Komisja Bioetyczna 
zatwierdziła protokół badania (nr 135/2017). Pierwszorzę-
dowym punktem końcowym było porównanie średnic balo-
nów uzyskanych w ilościowej ocenie angiograficznej (QCA, 
quantitative coronary angiography) do średnic deklarowanych 
przez producenta, osiągniętych przy określonych ciśnieniach. 
Wyniki: Do badania zakwalifikowano 21 pacjentów. U więk-
szości przypadków zdiagnozowano chorobę wielonaczyniową 
(61,9%) i zwężenia o umiarkowanym stopniu złożoności (typ 
B1 — 71,4%, typ B2 — 4,8%). Zmiany zlokalizowane były 
najczęściej w tętnicy okalającej (47,6%, n = 10). Wskaźnik 
skuteczności urządzenia wyniósł 100%. Wszystkie zabiegi wyko-
nano za pomocą cewnika prowadzącego 6F (100%), a w 95,2% 
(n = 20/21) zastosowano dostęp promieniowy. Nie było znaczą-
cych różnic między QCA a oczekiwanymi średnicami balonu przy 
zastosowaniu ciśnienia nominalnego ani w predilacji (2,32 ± 0,31 
mm w porównaniu z 2,38 ± 0,43 mm, D 2,5%), ani w postdilata-
cji (2,90 ± 0,38 mm w porównaniu z 2,96 ± 0,47 mm, D 2,0%). 
Odnotowano tylko dwa przypadki dyssekcji (1 typ A i 1 typ B). 
Wnioski: Przedstawione dane potwierdzają skuteczność i profil 
bezpieczeństwa cewników balonowych Balton NC. Wskaźnik 
skuteczności urządzenia wyniósł 100% i nie było poważnych 
powikłań. W analizie QCA cewniki Balton NC osiągnęły założone 
średnice i długości przy określonych ciśnieniach.
Słowa kluczowe: angioplastyka balonowa, niepodatny cewnik 
balonowy, ilościowa analiza angiograficzna 
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INTRODUCTION
Balloon catheters are the basis for everyday catheter 
laboratory work. The construction of standard pro-
ducts is well established and the principal function 
of the balloon has not changed much in the last 
15 years. The materials, however, are better now 
and stents and drugs have been added what aim 
to stabilize the dilatatory effect of the balloon, so 
that nearly every PCI is now finished with a stent. 
With the treatment of ever increasingly complicated 
atherosclerotic disease, predilatation prior to stent 
deployment and to some degree post-dilatation 
are now the main indications. The standard con-
struction principle for intracoronary catheters is the 
monorail system, which is best understood from its 
function [1]. 
The evolution of balloon catheter systems was 
dominated by a consecutive series of essential 
developments: non-compliant balloons, miniaturiza-
tion, steerable catheters, catheter exchange and the 
combination of these developments in one catheter. 
Grüntzig’s solution to treat stenoses in atheroscle-
rotic arteries was a non-compliant “sausage-like” 
balloon where pressure is transformed into radial 
force during inflation, evenly distributed over the 
balloon and directed toward the circumference [2]. 
Nowadays, non-complaint balloon catheters are 
used to predilate heavily calcified lesions before 
stenting to postdilate the implanted stent to optimize 
its parameters to finalize bifurcation treatment in 
final kissing balloon technique as well as to treat 
restenosis, especially in implanted earlier stents. The 
aim of this paper was to verify clinical effectiveness 
and safety profile of the new non-complaint balloon 
catheter (Balton, Poland).
METHODS
Device description
Coronary angioplasty catheter manufactured by 
the Balton Company is a Rapid Exchange catheter 
with a high pressure non-compliant balloon near 
the distal tip. The distal section of the catheter is 
dual lumen. The outer lumen is used for inflation of 
the balloon, and the inner lumen is used for guide 
wire (0.014”/0.36 mm). The proximal section of the 
catheter is a single-lumen. Catheter includes radio-
paque markers aiding in the precision placement 
of the catheter’s balloon in a vessel. The balloon 
diameter ranges from 1.25 mm to 6 mm and the 
balloon length — from 8 mm to 40 mm.
Study population and study design
It was the first-in-man analysis of the use of Balton NC 
balloon angioplasty catheter in patients undergoing 
percutaneous coronary interventions. There were 
included consecutive patients with age ≥ 18 years 
old, with coronary artery disease undergoing per-
cutaneous coronary interventions in lesion requiring 
predilatation or postdilatation and who signed the 
informed consent. The study was conducted in Au-
gust 2018 in the Department of Invasive Cardiology, 
Central Clinical Hospital of the Ministry of Interior 
and Administration. The local IRB approved the 
study protocol (No 135/2017).
Interventional procedure, device description  
and concomitant medication
There were assessed 21 Balton NC balloon angio-
plasty catheters, in which 8 were assessed in pre-
dilatation and 13 — in postdilatation applications. 
The example procedure is presented in the Figure 1. 
The study protocol was as follows:
1.  Lesion assessment according to ACC/AHA clas-
sification
2.  Lesion visualization in two views optimal for QCA 
measurements. All measurements repeated in 
the chosen views.
3.  Predilatation with the assessed device — QCA 
measurements including balloon’s length, dia-
meter (D) mean, Dmax, Dmin with registered applied 
pressures.
4.  QCA measurements after predilatations (2 views).
5.  QCA measurements during stent implantation.
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7.  QCA measurements during postdilatations.
8.  QCA measurements after postdilatations.
9.  TIMI blood flow assessment before and after 
procedure.
10.  Operator’s assessment including visibility, flexi-
bility, trackability and pushability.
All angiograms were recorded after intracoronary 
administration of 200 μg of nitroglycerin. Two or-
thogonal views were chosen to visualize the target 
lesion. A quantitative angiographic analysis was 
performed using CAAS QCA version 8.0 (Pie Medical, 
the Netherlands). Catheter calibration was performed 
in all cases. The following parameters were calcula-
ted: lesion length, reference vessel diameter (RVD), 
minimal lumen diameter (MLD), % diameter stenosis 
(%DS). All reference diameters were measured 
5 mm from the end of angiographically visible plaque 
without use of interpolations (user defined refe-
rence diameters). Percent diameter stenosis (using 
parameters from each segment) was measured for 
each vessel using the following formula: %DS = 
[1 — (MLD/RVD)] *100% [3]. 
Additionally, the following QCA parameters were 
recorded [4]: 
■■ stretch, that is, the measured maximal size in 
diameter of the inflated balloon, assuming unifor-
mity along its entire length during inflation minus 
the minimal lumen diameter; 
■■ recoil, that is, the difference between the me-
asured maximal balloon size and the subsequent 
residual minimal lumen diameter.
Additionally, to measure Balton NC balloon com-
pliance we compared the mean diameter obtained 
during the procedure to the expected diameter as-
sessed in vitro. %D was calculated as follows: %D 
= (expected diameter — QCA diameter)/expected 
diameter * 100%.
Endpoints
The primary endpoint was to compare balloon dia-
meters obtained in QCA to diameters declared by 
the producer reached at certain pressures. 
Statistical analysis:
Continuous variables were presented as mean ± SD. 
Categorical data were presented as numbers (%). 
Statistical analyses were performed using R 3.0.2 
for OS (R Foundation, Vienna, Austria).
RESULTS
Baseline characteristics
A total of 21 patients were enrolled to assess Balton 
NC balloon catheters performance in August 2018 
in the Department of Invasive Cardiology Central 
Clinical Hospital of the Ministry of Interior and Ad-
ministration, Warsaw, Poland. The detailed clinical 
characteristics is presented below (Table 1).
Table 1. Baseline clinical characteristics
Baseline clinical characteristics n = 21 (%)
Age [years] 67.3 ± 4.7
Men 21 (100)
Hypertension 20 (95.2)
Hypercholesterolemia 11 (52.4)
Diabetes type 2 10 (47.6)
Prior MI 10 (47.6)
Prior PCI 11 (52.4)
CABG 0
Chronic kidney disease 5 (23.8)
Clinical indication for PCI
planned PCI 17 (81)
UA 0
NSTEMI 4 (19)
STEMI 0
MI: myocardial infarction; PCI: percutaneous coronary inter-
ventions; CABG: coronary artery bypass graft; UA: unstable 
angina; NSTEMI: non-ST-elevation myocardial infarction; STEMI: 
ST-elevation myocardial infarction
In most cases patients presented with the multivessel 
disease (61.9%) and lesions of the moderate com-
plexity (type B1 — 71.4%, type B2 — 4.8%). Lesions 
were located most frequently in the left circumflex 
artery (47.6%, n = 10). More details are presented 
below (Table 2).
Procedural characteristics
The main procedural variables are presented in 
Table 3. The device success rate was 100%. All pro-
cedures were performed via the 6F guiding catheter 
(100%) and in 95.2% (n = 20/21). The radial access 
was preferred. 
QCA analysis
Table 4 presents quantitative coronary angiography 
(QCA) analysis of each step of PCI, with additional 
marking for mean diameter, minimal diameter and 
7htt
ps
://j
ou
rn
als
.vi
am
ed
ica
.pl
/ka
rd
iol
og
ia_
inw
az
yjn
amaximal diameter for balloons used in predilatations, 
for stents and for balloons used in postdilatations.
Additionally, in Table 5 data on expected and calcu-
lated by QCA mean balloon diameters used in pre-
dilatations and postdilatations at nominal pressures 
applied and on RBP applied are presented.
Safety evaluation
Regarding safety profile there was no severe adverse 
events, no perforation or systemic bleeding compli-
cations (e.g. gastrointestinal bleeding or intracranial 
hemorrhage). The detailed data are shown in Table 6. 
LIMITATIONS
This registry has several limitations that should 
be acknowledged. First of all, the sample size was 
relatively small. Another limitation of this registry 
is due to its non-randomized manner and all known 
drawbacks of registry studies.
CONCLUSIONS
The presented data confirm the effectiveness and 
safety profile of Balton NC balloon catheters. There 
were no severe adverse events, the device success 
rate was 100%, and there were no severe complica-
tions. The dissection incidence was less than 10%. 
However, this is the normal mechanism of lumen 
enlargement and the mechanism of action of plain 
old balloon angioplasty. The rate of complications 
Table 2. Angiographic characteristics
Parameter n = 21 (%)
Multivessel disease 13 (61.9)
Lesion type
A 2 (9.5)
B1 15 (71.4)
B2 1 (4.8)
C 3 (14.3)
Lesion location
LM 1 (4.8)
LAD 8 (38.1)
LCx 10 (47.6)
RCA 2 (9.5)
Vessel tortuosity 
None — mild 15 (71.4)
Moderate — severe 6 (28.6)
Calcification
None — mild 16 (76.2)
Moderate — severe 5 (23.8)
LIMA: left internal mammary artery; LAD: left anterior descending 
artery; LM: left main stem; LCx: left circumflex artery; RCA: right 
coronary artery; VG: venous graft
Table 3. Procedural characteristics
Parameter n = 21 (%)
Device success 21 (100)
Predilatation — balloon nominal diameter [mm] 2.38 ± 0.43
Predilatation — balloon nominal length [mm] 16.88 ± 2.50
Stent — nominal diameter [mm] 3.07 ± 0.54
Stent — nominal length [mm] 19.90 ± 5.58
Postdilatation — balloon nominal diameter [mm] 2.96 ± 0.47
Postdilatation — balloon nominal length [mm] 12.92 ± 3.01
Maximal predilatation pressure [atm] 16.4 ± 4.4
Maximal stent deployment pressure [atm] 11.3 ± 3.24
Maxiaml postdilatation pressure [atm] 22.1 ± 3.9
Balloon: artery ratio (predilatation) 0.76 (range: 0.73–0.83)
Balloon: artery ratio (postdilatation) 0.98 (range: 0.95–1.02)
Vascular access radial/femoral 20 (95.2)/1 (4.8)
Guiding catheter 6F/7F 21 (100)/0
8Ka
rd
iol
og
ia 
Inw
az
yjn
a n
r 6
 (1
3)
, R
OK
 20
18 Table 4. QCA analysis
Baseline Predilatation Postpredi-
latation
Stent impl. Post stent 
impl.
Postdilata-
tion
Final
MLD 0.72 ± 0.12 1.64 ± 
0.21
2.69 ± 
0.23
2.92 ± 
0.14
%DS 76.4 ± 11.2% – 45.5 ± 
23.1
– 13.4 ± 4.3 – 4.8 ± 
1.9
Ref. D 3.05 ± 0.23 – 3.01 ± 
0.32
– 3.11±0.23 – 3.07 ± 
0.07
Dmean – 2.32 ± 0.31 – 2.88 ± 
0.44
– 3.07 ± 
0.12
–
Dmin – 2.24 ± 0.29 – 2.77 ± 
0.32
– 2.99 ± 
022
–
Dmax – 2.36 ± 0.41 – 2.98 ± 
0.22
– 3.11 ± 
0.12
–
length – 16.4 ± 3.4 – 19.8±0.12 – 10.9 ± 2.3 –
Stretch 1.6 ± 0.09 0.42 ± 
0.04
recoil 0.68 ± 
0.11
0.19 ± 
0.02
Table 5. QCA-based and expected balloon diameters
Predilatation, n = 8 Nominal pressure (12 atm) RBP (20 atm)
QCA Expected %D QCA Expected %D
Balloon diameter 2.32 ± 0.31 2.38 ± 0.43 2.5% 2.54 ± 0.33 2.59 ± 0.23 1.9%
Postdilatation, n = 13
Balloon diameter 2.90 ± 0.38 2.96 ± 0.47 2.0% 3.11 ± 0.12 3.22 ± 0.29* 3.4%
*difference statistically significant
Table 6. Procedural complications
Complication No (%)
n = 21
Coronary artery perforation 0
Coronary artery dissection 2 (9.5)
Distal embolization 0
Slow flow/no reflow phenomenon 0
Side branch occlusion after balloon 
dilatation
0
Systemic bleeding complications 0
Access site complications 0
hematoma 0
pseudoaneurysm 0
a-v fistula 0
infection 0
Table 7. Coronary artery dissection classification
Type of dissection No (%)
n = 21
A 1 (4.7)
B 1 (4.7)
C 0
D 0
E 0
F 0
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and immediate outcomes are similar to other studies 
describing balloon angioplasty procedures [5–8].
In the QCA analysis Balton NC balloon catheters 
reached assumed diameters and lengths at given 
pressures. Additionally, the Balton NC balloon met 
the non-compliance criteria defined earlier, i.e. com-
pliance < 10%. Worth stressing is the fact that com-
pliance index was no larger than 3.4% [9]. 
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